[go: up one dir, main page]

WO1996039425A3 - Composes ayant une activite antagoniste de la bradykinine et une activite agoniste mu-opioïde - Google Patents

Composes ayant une activite antagoniste de la bradykinine et une activite agoniste mu-opioïde Download PDF

Info

Publication number
WO1996039425A3
WO1996039425A3 PCT/US1996/008923 US9608923W WO9639425A3 WO 1996039425 A3 WO1996039425 A3 WO 1996039425A3 US 9608923 W US9608923 W US 9608923W WO 9639425 A3 WO9639425 A3 WO 9639425A3
Authority
WO
WIPO (PCT)
Prior art keywords
activity
compounds
bradykinin antagonistic
opioid
bradykinin
Prior art date
Application number
PCT/US1996/008923
Other languages
English (en)
Other versions
WO1996039425A2 (fr
Inventor
John C Cheronis
Albert Gyorkos
Lyle W Spruce
Eric T Whalley
Original Assignee
Cortech Inc
John C Cheronis
Albert Gyorkos
Lyle W Spruce
Eric T Whalley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/465,672 external-priority patent/US5843900A/en
Application filed by Cortech Inc, John C Cheronis, Albert Gyorkos, Lyle W Spruce, Eric T Whalley filed Critical Cortech Inc
Priority to EP96918098A priority Critical patent/EP0832106A2/fr
Priority to AU60444/96A priority patent/AU6044496A/en
Publication of WO1996039425A2 publication Critical patent/WO1996039425A2/fr
Publication of WO1996039425A3 publication Critical patent/WO1996039425A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/18Kallidins; Bradykinins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention se rapporte à des hétérodimères pharmaceutiquement efficaces comprenant un composant antagoniste de la bradykinine lié de manière covalente à un composant agoniste mu-opioïde.
PCT/US1996/008923 1995-06-05 1996-06-04 Composes ayant une activite antagoniste de la bradykinine et une activite agoniste mu-opioïde WO1996039425A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP96918098A EP0832106A2 (fr) 1995-06-05 1996-06-04 Composes ayant une activite antagoniste de la bradykinine et une activite agoniste mu-opio de
AU60444/96A AU6044496A (en) 1995-06-05 1996-06-04 Compounds having bradykinin antagonistic activity and mu-opi oid agonistic activity

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/465,672 US5843900A (en) 1991-04-01 1995-06-05 Bradykinin antagonists
US08/465,672 1995-06-05
US64716096A 1996-05-21 1996-05-21
US08/647,160 1996-05-21

Publications (2)

Publication Number Publication Date
WO1996039425A2 WO1996039425A2 (fr) 1996-12-12
WO1996039425A3 true WO1996039425A3 (fr) 1997-01-30

Family

ID=27041368

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/008923 WO1996039425A2 (fr) 1995-06-05 1996-06-04 Composes ayant une activite antagoniste de la bradykinine et une activite agoniste mu-opioïde

Country Status (4)

Country Link
EP (1) EP0832106A2 (fr)
AU (1) AU6044496A (fr)
TW (1) TW407159B (fr)
WO (1) WO1996039425A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262265B1 (en) * 1999-06-18 2001-07-17 Microgenics Corporation Non-hydrolyzable analogs of heroin metabolites suitable for use in immunoassay
EP1312923B1 (fr) * 2001-11-16 2007-03-28 Randox Laboratories Ltd. Méthode et trousse pour détecter, ou quantifier, des métabolites de fentanyl et des métabolites de fentanyl analogues
CN100402084C (zh) * 2001-11-16 2008-07-16 兰多克斯实验室有限公司 检测或定量芬太尼或其类似物的代谢物的方法和试剂盒
JP2008519837A (ja) * 2004-11-10 2008-06-12 ベーリンガー インゲルハイム ケミカルズ インコーポレイテッド フェンタニル中間体の生成方法
US7238791B1 (en) * 2005-12-16 2007-07-03 Roche Diagnostics Operations, Inc. 6-monoacetylmorphine derivatives useful in immunoassay
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
MX2012000980A (es) * 2009-07-21 2012-06-12 Nektar Therapeutics Conjugados de agonistas de oligómeros-opioides.

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0370453A2 (fr) * 1988-11-24 1990-05-30 Hoechst Aktiengesellschaft Peptides avec action inhibitrice de la bradykinine
WO1992017201A1 (fr) * 1991-04-01 1992-10-15 Cortech, Inc. Antagonistes de la bradykinine
WO1992018156A1 (fr) * 1991-04-19 1992-10-29 Nova Technology Limited Partnership Peptides antagonistes de bradykinine
WO1994011021A1 (fr) * 1992-11-10 1994-05-26 Cortech, Inc. Antagoniste de bradykinine
WO1995024422A1 (fr) * 1994-03-09 1995-09-14 Cortech, Inc. Peptides antagonistes de la bradykinine contenant des glycines substituees en n
WO1996016081A1 (fr) * 1994-11-18 1996-05-30 University Technology Corporation Peptides antagonistes de la bradykinine contenant des acides amines a substituants indane

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0370453A2 (fr) * 1988-11-24 1990-05-30 Hoechst Aktiengesellschaft Peptides avec action inhibitrice de la bradykinine
WO1992017201A1 (fr) * 1991-04-01 1992-10-15 Cortech, Inc. Antagonistes de la bradykinine
WO1992018156A1 (fr) * 1991-04-19 1992-10-29 Nova Technology Limited Partnership Peptides antagonistes de bradykinine
WO1994011021A1 (fr) * 1992-11-10 1994-05-26 Cortech, Inc. Antagoniste de bradykinine
WO1995024422A1 (fr) * 1994-03-09 1995-09-14 Cortech, Inc. Peptides antagonistes de la bradykinine contenant des glycines substituees en n
WO1996016081A1 (fr) * 1994-11-18 1996-05-30 University Technology Corporation Peptides antagonistes de la bradykinine contenant des acides amines a substituants indane

Also Published As

Publication number Publication date
EP0832106A2 (fr) 1998-04-01
TW407159B (en) 2000-10-01
AU6044496A (en) 1996-12-24
WO1996039425A2 (fr) 1996-12-12

Similar Documents

Publication Publication Date Title
AU1273195A (en) Tachykinin antagonists
AU1842995A (en) N-acylpiperidine tachykinin antagonists
AU4343796A (en) Tachykinin antagonists
AU3446695A (en) Baseball or softball glove
AU3071697A (en) Multi-layered barrier glove
AU2524995A (en) Neurokinine (tachykinine) antagonists
AU1441695A (en) Fibrinogen receptor antagonists
AU1047095A (en) Improved ball glove
AU7947594A (en) Substituted amides as tachykinin antagonists
AU5603094A (en) N,n-diacylpiperazine tachykinin antagonists
AU3899997A (en) Muscarinic antagonists
AU7224396A (en) Pharmaceutically active quinazoline compounds
AU3998593A (en) Angiotensin II antagonists
AU3953795A (en) Bicyclic neuropeptide y receptor antagonists
AU5636398A (en) Firefighter glove
HU9601176D0 (en) Adhesion-receptor antagonists
AU1742495A (en) Baseball glove having enhanced flexibility
AU2637095A (en) Antimicrobial glove
SI0854867T1 (en) Tetrahydroquinolines as nmda antagonists
AU4931693A (en) Ibuprofen-h2 antagonist combinations
SG50426A1 (en) Lhrh antagonists
WO1996039425A3 (fr) Composes ayant une activite antagoniste de la bradykinine et une activite agoniste mu-opioïde
GB9518027D0 (en) Pharmacologically active compound
AU3193097A (en) Il-6 and il-6-receptor derived peptides having il-6 antagonistic or agonistic activity
AU1574995A (en) Tachykinins antagonists

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1996918098

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996918098

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1996918098

Country of ref document: EP